Upgrade to SI Premium - Free Trial

Bristol-Myers Squibb (BMY) Tops Q3 EPS by 12c; Boosts FY16 Outlook; Approves New $3B Stock Buyback Plan

October 27, 2016 7:00 AM
Bristol-Myers Squibb (NYSE: BMY) reported Q3 EPS of $0.77, $0.12 better than the analyst estimate of $0.65. Revenue for the ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Earnings Guidance Hot Buybacks Hot Earnings Hot Guidance Stock Buybacks

Next Articles